Back to HALO
Oliver Luxxe Assets LLC → HALO
Oliver Luxxe Assets LLC HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$3.2M
Q3 2026
Peak value
$3.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3.1M |
| Q4 2025 | $2.8M |
| Q1 2026 | $3.2M |
| Q2 2026 | $2.6M |
| Q3 2026 | $3.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.2M | 28.6K | — | — |
| Q2 2026 | $2.6M | 33.0K | — | — |
| Q1 2026 | $3.2M | 50.2K | — | — |
| Q4 2025 | $2.8M | 42.0K | — | — |
| Q3 2025 | $3.1M | 41.8K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M
$176.7M
$148.6M